Renaissance Capital logo

RCOR.XX News

US IPO Weekly Recap: ORIC pops 61% and SPACs make a comeback

ORIC

The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four IPOs and one SPAC...read more

Blank check Chardan Healthcare Acquisition 2 prices IPO at $10

Renovacor (Chardan Healthcare Acquisition 2) logo

Chardan Healthcare Acquisition 2, the second blank check company formed by Chardan Capital targeting the healthcare industry, raised $85 million by offering 8.5 million units at $10. Each unit consists of one share of common stock and one warrant,...read more

US IPO Week Ahead: 1 cannabis SPAC lights up a dim IPO market

CGROU

Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. ...read more

US IPO Weekly Recap: 1 biotech prices ahead of the IPO market’s quarantine

IMRA

As a rule, if March Madness gets canceled, then the IPO window is closed. Remarkably, one biotech pulled off an IPO this week, along with a blank check company. Outside of a few more SPACs, the IPO market may essentially shut down for months, as...read more